Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market
Background: Diversion of buprenorphine (BPN) has been described in settings where it is legally prescribed and has resulted in increasing concern. To address this concern, co-formulation of buprenorphine/naloxone (BPN/NLX) replaced buprenorphine alone in Malaysia in December 2006. Methods: To assess...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2009
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/4596/1/Lack_of_Reduction_in_Buprenorphine_Injection_After_Introduction_of_Co-Formulated_Buprenorphine-Naloxone_to_the_Malaysian_Market.pdf |